(Q35939026)

11 August 2017

1 reference

title

Biochemistry and biology of mammalian DNA methyltransferases (English)

1 reference

11 August 2017

3

1 reference

11 August 2017

Hermann A

1

1 reference

PubMed ID

15526163

11 August 2017

Gowher H

series ordinal

2

1 reference

PubMed ID

15526163

11 August 2017

language of work or name

1 reference

1 October 2004

1 reference

Cellular and Molecular Life Sciences

11 August 2017

1 reference

11 August 2017

61

1 reference

11 August 2017

2571-2587

1 reference

11 August 2017

19-20

1 reference

https://scigraph.springernature.com/pub.10.1007/s00018-004-4201-1

11 August 2017

0 references

cites work

Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

1 reference

12 December 2020

Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion

1 reference

12 December 2020

Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation

1 reference

12 December 2020

Sotalol testing unmasks altered repolarization in patients with suspected acquired long-QT-syndrome--a case-control pilot study using i.v. sotalol

1 reference

12 December 2020

Amiodarone versus sotalol for atrial fibrillation

1 reference

12 December 2020

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

1 reference

12 December 2020

Intravenous amiodarone for acute heart rate control in the critically ill patient with atrial tachyarrhythmias

1 reference

12 December 2020

Pharmacological cardioversion of atrial fibrillation with vernakalant: evidence in support of the ESC Guidelines

1 reference

12 December 2020

European Heart and Rhythm Association guidelines on new oral anticoagulants: A bold step forward

1 reference

12 December 2020

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation

1 reference

12 December 2020

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

1 reference

12 December 2020

A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation

1 reference

12 December 2020

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

1 reference

12 December 2020

Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach

1 reference

12 December 2020

Increased mortality after dronedarone therapy for severe heart failure

1 reference

12 December 2020

1 reference

12 December 2020

Electrophysiological effects of ibutilide in patients with accessory pathways

1 reference

12 December 2020

Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial

1 reference

12 December 2020

Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm

1 reference

12 December 2020

Rhythm control versus rate control for atrial fibrillation and heart failure

1 reference

12 December 2020

Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter

1 reference

12 December 2020

Left atrial appendage closure followed by 6 weeks of antithrombotic therapy: a prospective single-center experience

1 reference

12 December 2020

Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study

1 reference

12 December 2020

Optimal treatment strategy for patients with paroxysmal atrial fibrillation: J-RHYTHM Study

1 reference

12 December 2020

Side effects of long-term amiodarone therapy

1 reference

12 December 2020

Effect of dronedarone on cardiovascular events in atrial fibrillation

1 reference

12 December 2020

Clinical organ toxicity of antiarrhythmic compounds: ocular and pulmonary manifestations

1 reference

12 December 2020

Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation

1 reference

12 December 2020

Cardioversion for atrial fibrillation in current European practice: results of the European Heart Rhythm Association survey

1 reference

12 December 2020

Vernakalant hydrochloride for the rapid conversion of atrial fibrillation after cardiac surgery: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Dabigatran versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Negative inotropic and lusitropic effects of intravenous amiodarone in conscious rats

1 reference

12 December 2020

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

1 reference

12 December 2020

β-Adrenergic Antagonist Inhibition of Hepatic 3,5,3′-Triiodothyronine Production*

1 reference

12 December 2020

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

1 reference

12 December 2020

Quality-of-life assessment in patients with paroxysmal atrial fibrillation or paroxysmal supraventricular tachycardia.

1 reference

12 December 2020

New-onset atrial fibrillation: sex differences in presentation, treatment, and outcome

1 reference

12 December 2020

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

12 December 2020

A comparison of rate control and rhythm control in patients with atrial fibrillation

1 reference

12 December 2020

Amiodarone versus propafenone for conversion of chronic atrial fibrillation: results of a randomized, controlled study.

1 reference

12 December 2020

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association

1 reference

12 December 2020

Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation

1 reference

12 December 2020

Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter

1 reference

12 December 2020

Antiarrhythmic actions of intravenous ibutilide compared with procainamide during human atrial flutter and fibrillation: electrophysiological determinants of enhanced conversion efficacy

1 reference

12 December 2020

Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.

1 reference

12 December 2020

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

1 reference

12 December 2020

Giant T–U Waves Precede Torsades de Pointes in Long QT Syndrome

1 reference

12 December 2020

Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine

1 reference

12 December 2020

Apixaban versus warfarin in patients with atrial fibrillation

1 reference

12 December 2020

Cardiac β-adrenoceptor modulation by amiodarone

1 reference

12 December 2020

Evidence-based analysis of amiodarone efficacy and safety

1 reference

12 December 2020

Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study

1 reference

12 December 2020

Challenging the superiority of amiodarone for rate control in Wolff-Parkinson-White and atrial fibrillation

1 reference

12 December 2020

The mechanism of atrial antiarrhythmic action of RSD1235.

1 reference

12 December 2020

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation

1 reference

12 December 2020

Outcome parameters for trials in atrial fibrillation: executive summary

1 reference

12 December 2020

Efficacy and Safety of Apixaban in Patients After Cardioversion for Atrial Fibrillation

1 reference

12 December 2020

Safety of dronedarone in routine clinical care.

1 reference

12 December 2020

Lenient versus strict rate control in patients with atrial fibrillation

1 reference

12 December 2020

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

12 December 2020

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

1 reference

12 December 2020

10.1007/S00018-004-4201-1

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15526163